iMD Companies, Inc. (OTC: ICBU) announced today that it has entered into advanced due diligence on two potential acquisition targets, one in the cryptocurrency infrastructure sector and the other in the medical technology space. The company, based in Rancho Cordova, CA, is pursuing these opportunities as part of its strategic focus on identifying and investing in high-growth industries supported by scalable technologies and long-term market demand.
According to the press release, the company believes these potential acquisitions could strengthen its position across emerging sectors and support future revenue expansion. Richard Wilson, CEO of iMD Companies, stated, "We are encouraged by the progress we’ve made in evaluating these opportunities. Our approach remains disciplined and focused on identifying assets that can deliver sustainable growth and long-term value for our shareholders."
The due diligence process is ongoing, with completion anticipated in the coming weeks. iMD Companies will provide updates as appropriate as evaluations progress. The company has committed to maintaining transparency with its shareholders and will continue to communicate material developments in a timely manner.
This announcement comes as iMD Companies, a Florida corporation focused on acquisitions and technology in the crypto currency, blockchain, and application development markets, seeks to expand its portfolio. The company's shares trade on the OTC Markets under the ticker ICBU. More information about iMD Companies can be found on its website at imdcompaniesinc.com and on OTC Markets. The company also provides updates on its social media channels, including following @imd_inc on X.
The forward-looking statements in the press release highlight the inherent risks and uncertainties associated with such acquisitions. The company cautioned that actual future results and trends may differ materially from what is forecast due to a variety of factors, and it undertakes no obligation to update these statements.
For iMD Companies, the successful completion of either acquisition could mark a significant step in its growth strategy. The cryptocurrency infrastructure sector continues to evolve with increasing institutional interest and regulatory clarity, while the medical technology space offers opportunities driven by innovation and demographic trends. The company's disciplined approach to evaluating these assets may position it to capitalize on these trends if the deals proceed.
Investors and stakeholders will be watching closely for further updates as the due diligence progresses. The company’s commitment to transparency and timely communication will be key in maintaining shareholder confidence during this evaluation period.
